课题基金 / 基金详情

Feasibility of Kinarm-based Assessment of Neurological Impairment in Primary Brain Tumour Patients

Feasibility of Kinarm-based Assessment of Neurological Impairment in Primary Brain Tumour Patients
基于 Kinarm 的原发性脑肿瘤患者神经损伤评估的可行性
批准号：
466909
负责人：
Lott Jack
金额：
$1.27万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466909&lang=en
关键词：
Brain Tumour Surgery Clinical Assessment Clinical Neuroscience Kinarm Neurological Impairment Neurosurgery Primary Brain Tumours Robotic Assessment

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Primary brain tumour patients experience neurological impairment caused by the tumour itself or by surgical resection. Our overall goal is to develop novel approaches to optimize surgical intervention and minimize deficits. Clinical assessment methods are
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金